Articles by Bikash Chatterjee

1. Navigating The FDA's Emergency Use Authorization Process 5/14/2020

   The FDA has been authorized to grant Emergency Use Authorizations for SARS-CoV-2. This will impact both internal manufacturing and the CDMOs that drug sponsors employ. 

2. Ensuring Quality In Ventilator Production Scale-Up For COVID-19 4/24/2020

   Chief Editor Louis Garguilo asked Outsourced Pharma Advisory Board member and COO/CSO of Pharmatech Associates, Inc., Bikash Chatterjee, to update our readers periodically on what he is seeing and experiencing during this coronavirus pandemic. This is his first update.